Skip to content

Gene Tech Regulator Considering Releasing Mosquitoes

Oxitec has now set its sights on Australia, with an application to release genetically modified mosquitoes in Queensland currently under consideration.

Photo by Syed Ali / Unsplash

DTNZ

Critics warn of dangers as genetically modified mosquitoes spread across continents in Bill Gates-backed ventures.

In a controversial effort to combat mosquito-borne diseases, Bill Gates backed biotech company Oxitec released genetically modified Aedes aegypti mosquitoes in Ohio earlier this year, sparking alarm among environmental activists and concerned citizens. Critics warn that this unprecedented experiment could lead to ecological disaster rather than the intended eradication of deadly diseases.

Oxitec has now set its sights on Australia, with an application to release genetically modified mosquitoes in Queensland currently under consideration. A draft risk assessment and risk management plan (RARMP) is being prepared for release in March, after which the public will have 30 days to file submissions.

The modified mosquitoes, designed to curb populations of disease-spreading females, are engineered to produce non-viable female offspring. The males, which do not bite, are meant to propagate this trait, theoretically collapsing local mosquito populations over time. Gates has hailed the technology as a revolutionary “mosquito versus mosquito” solution to global health challenges, including malaria, dengue, and Zika.

However, skeptics question the true purpose behind these releases.

“Australia doesn’t have a significant malaria problem,” noted one concerned observer in response to the news on X. “This isn’t about saving lives – it feels like an experiment being disguised as humanitarian aid.”

Critics argue that Western nations like Australia, equipped with advanced healthcare systems, do not need such high-risk interventions. “We have the means to treat malaria with full recovery. What’s really being released here?” asked a local activist.

Concerns also stem from Oxitec’s past trials in Africa, where critics argue that impoverished communities were used as testing grounds without adequate transparency or consent.

Gates and Oxitec cite Brazil’s trials as proof of success, claiming reduced cases of dengue fever with no adverse environmental impacts. Yet, the release of over a billion genetically modified mosquitoes worldwide has prompted fears of unforeseen ecological consequences and genetic spillover.

This article was originally published by the Daily Telegraph New Zealand.

Latest